PharmaShots Weekly Snapshots (June 07 – 11, 2021)

Vertex and CRISPR Therapeutics Present New Data of CTX001 from 22 Patients with TDT and SCD at EMA 2021

Published: June 11, 2021 | Tags: Vertex, CRISPR Therapeutics, CTX001, TDT, SCD, EMA 2021

AbbVie Reports Results of Four-Year Follow-Up Analysis in P-III CLL14 Trial for Venclyxto/Venclexta to Treat Chronic Lymphocytic Leukemia

Published: June 11, 2021 | Tags: AbbVie, Four-Year, Follow-Up Analysis, P-III, CLL14 Trial, Venclyxto, Venclexta, Chronic Lymphocytic Leukemia

Roche Reports New Interim Data of JEWELFISH & RAINBOWFISH Studies for Evrysdi (risdiplam) to Treat Spinal Muscular Atrophy

Published: June 11, 2021 | Tags: Roche, JEWELFISH, RAINBOWFISH, Studies, Evrysdi, risdiplam, Spinal Muscular Atrophy

Verona Pharma Signs $219M Agreement with Nuance Pharma to Develop and Commercialize Ensifentrine in Greater China

Published: June 11, 2021 | Tags: Verona Pharma, $219M, Nuance Pharma, Develop, Commercialize, Ensifentrine, Greater China

BeyondSpring Presents Results of Plinabulin in P-III PROTECTIVE-1 Study for Prevention of Chemotherapy-Induced Neutropenia at ASCO 2021

Published: June 11, 2021 | Tags: BeyondSpring, Plinabulin, P-III, PROTECTIVE-1 Study, Chemotherapy-Induced Neutropenia, ASCO 2021

Gilead’s Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA’s Approval for Children with Chronic Hepatitis C Infection

Published: June 11, 2021 | Tags: Gilead, Epclusa, Sofosbuvir, Velpatasvir, US, FDA, Approval, Chronic Hepatitis C Infection

Takeda Expands its License Agreement with Codexis to Discover Novel Gene Therapies for Fourth Rare Genetic Disorders

Published: June 10, 2021 | Tags: Takeda, License Agreement, Codexis, Novel Gene Therapies, Rare Genetic Disorders

BeiGene Signs an Exclusive Worldwide Collaboration with Shoreline to Develop and Commercialize Genetically Modified NK Cell Therapies

Published: June 10, 2021 | Tags: BeiGene, Shoreline, Develop, Commercialize, Genetically Modified NK Cell Therapies

Vertex’s Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA’s Approval in Children Aged 6 to 11 with Certain Mutations in Cystic Fibrosis

Published: June 10, 2021 | Tags: Vertex, Trikafta, elexacaftor, tezacaftor, ivacaftor, US, FDA, Approval, Cystic Fibrosis

Hummingbird Collaborates with Novogene to Expand Precision Therapy Testing for NRG1-Fusion Driven Cancers in China

Published: June 10, 2021 | Tags: Hummingbird, Novogene, Precision Therapy Testing, NRG1-Fusion Driven Cancers, China

Inovio Expands its Partnership with Advaccine to Initiate P-III Efficacy Trial for INO-4800 to Treat COVID-19

Published: June 10, 2021 | Tags: Inovio, Advaccine, P-III, Efficacy Trial, INO-4800, COVID-19

Merck Signs ~$1.2B Supply Agreement with US Government for Molnupiravir to Treat COVID-19

Published: June 10, 2021 | Tags: Merck, ~$1.2B, Supply Agreement, US Government, Molnupiravir, COVID-19

AbbVie Collaborates with Caraway to Develop TMEM175 for Parkinson’s Disease and Other Related Disorders

Published: June 9, 2021 | Tags: AbbVie, Caraway, Develop, TMEM175, Parkinson’s Disease, Related Disorders

Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar, golimumab)

Published: June 9, 2021 | Tags: Bio-Thera, P-III, Clinical Trial, BAT2506, biosimilar, golimumab

Cardiff Oncology Reports First Patient Dosing in P-II Trial for Onvansertib + Irinotecan and 5-FU as a 2L Treatment for Metastatic Pancreatic Ductal Adenocarcinoma

Published: June 9, 2021 | Tags: Cardiff Oncology, P-II, Trial, Onvansertib, Irinotecan, 5-FU, Metastatic Pancreatic Ductal Adenocarcinoma

Pfizer’s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the US FDA’s Approval for the Prevention of Invasive Disease and Pneumonia

Published: June 9, 2021 | Tags: Pfizer, Prevnar 20, Pneumococcal 20-Valent Conjugate Vaccine, US, FDA, Approval, Invasive Disease, Pneumonia

Progentec Signs a Research Collaboration with GSK to Evaluate Proteomics and Digital Health Tools for SLE

Published: June 9, 2021 | Tags: Progentec, GSK, Proteomics, Digital Health Tools, SLE

Bayer to Advance its Investigational Cell and Gene Therapy for Parkinson’s Disease

Published: June 9, 2021 | Tags: Bayer, Cell Therapy, Gene Therapy, Parkinson’s Disease

AbbVie’s Rinvoq (upadacitinib) Receives the Health Canada’s Approval for the Treatment of Psoriatic Arthritis

Published: June 8, 2021 | Tags: AbbVie, Rinvoq, upadacitinib, Health Canada, Approval, Psoriatic Arthritis

BeiGene Reports NMPA’s Acceptance of sBLA for Tislelizumab to Treat MSI-H or dMMR Solid Tumors

Published: June 8, 2021 | Tags: BeiGene, NMPA, sBLA, Tislelizumab, MSI-H, dMMR Solid Tumors

Roche’s SARS-CoV-2 Antigen Test Receives CE mark For Self Testing of COVID-19 at Home

Published: June 8, 2021 | Tags: Roche, SARS-CoV-2 Antigen Test, CE mark, Self Testing, COVID-19

Janssen Discontinues its 2018 License Agreement with Argenx for Cusatuzumab

Published: June 8, 2021 | Tags: Janssen, Discontinues, 2018, License Agreement, Argenx, Cusatuzumab

MSD Animal Health Acquires LICA’s Assets to Enhance its Dairy Farm Management Solutions

Published: June 8, 2021 | Tags: MSD Animal Health, Acquires, LICA Assets, Dairy Farm Management Solutions

Biogen and Eisai’s Aduhelm (aducanumab-avwa) Receive the US FDA’s Accelerated Approval for Alzheimer Disease

Published: June 8, 2021 | Tags: Biogen, Eisai, Aduhelm, aducanumab-avwa, US, FDA, Accelerated Approval, Alzheimer Disease

SpringWorks and Seagen Enter into a Clinical Collaboration to Evaluate Nirogacestat + SEA-BCMA for R/R Multiple Myeloma

Published: June 7, 2021 | Tags: SpringWorks, Seagen, Nirogacestat, SEA-BCMA, R/R Multiple Myeloma

AstraZeneca Reports Updated Results of Imfinzi (durvalumab) in P-III PACIFIC Trial for Non-Small Cell Lung Cancer

Published: June 7, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab, P-III, PACIFIC Trial, Non-Small Cell Lung Cancer

AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III Head-to-Head ELEVATE-RR Trial for Chronic Lymphocytic Leukemia

Published: June 7, 2021 | Tags: AstraZeneca, Calquence, acalabrutinib, P-III, Head-to-Head ELEVATE-RR Trial, Chronic Lymphocytic Leukemia

Novo Nordisk’s Wegovy (semaglutide, 2.4mg) Receives the US FDA’s Approval for Weight Management in Adults with Obesity

Published: June 7, 2021 | Tags: Novo Nordisk, Wegovy, semaglutide, US, FDA, Approval, Weight Management, Obesity

ProMetic’ Ryplazim (plasminogen) Receives the US FDA’s Approval as First Treatment for Patients with Plasminogen Deficiency

Published: June 7, 2021 | Tags: ProMetic, Ryplazim, plasminogen, US, FDA, Approval, Plasminogen Deficiency

Novartis Presents Results of Iptacopan in P-II Study for IgA Nephropathy at ERA-EDTA Congress

Published: June 7, 2021 | Tags: Novartis, Iptacopan, P-II, Study, IgA Nephropathy, ERA-EDTA Congress

The post PharmaShots Weekly Snapshots (June 07 – 11, 2021) first appeared on PharmaShots.